ClinicalTrials.gov
public full text
Public Domain
Effects of Walnuts on Central Blood Pressure, Arterial Stiffness Indices, Lipoproteins, and Other CVD Risk Factors
This study will evaluate the effects of walnut-derived ALA and bioactives on multiple CVD risk factors, including central blood pressure, arterial stiffness indices, inflammatory markers, urinary isoprostanes, vascular adhesion markers, and changes in lipids and lipoproteins. Gut microbiome changes due to walnut consumption will also be assessed using the 16S rRNA gene.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Walnuts as an Infant Solid Food for Health#858183
- Study of the Impact of Trans Fatty Acids From Dairy Products on Cardiovascular Risk Factors#862078
- Kodo Millet Porridge and Its Effects on Gut Health and Metabolic Syndrome#1170591
- Mastiha Treatment for Obese With NAFLD Diagnosis#1161747
- Effect Partial Digested Triglycerides on Supply Long-chain Fatty Acids to Very Preterm Newborns#913366
Record · ID 994820
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive